Recursion Pharmaceuticals, Inc. (RXRX) Earnings
|
Expand Research on RXRX
| Next EPS Date | 11/11/26 | EPS Growth Rate | +38.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | +179.9% |
| Average % Move 1-Wk after EPS | -3.2% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$0.22 | N/A | N/A | $14.5M | N/A | N/A | N/A | ||
| 8/5/26 |
Q226 | -$0.25 | -$0.24 | -$0.01 | $7.67M | $12.15M | N/A |  | | Details | |
| 5/6/26 | Q126 | -$0.22 | -$0.26 | +$0.04 | $6.47M | $16.28M | N/A | | | Details | |
| 2/25/26 | Q425 | -$0.21 | -$0.30 | +$0.09 | $35.54M | $24.51M | N/A | | | Details | |
| 11/5/25 | Q325 | -$0.36 | -$0.37 | +$0.01 | $5.18M | $16.95M | N/A | | | Details | |
| 8/5/25 | Q225 | -$0.41 | -$0.35 | -$0.06 | $19.22M | $15.37M | N/A | | | Details | |
| 5/5/25 | Q125 | -$0.50 | -$0.49 | -$0.01 | $14.75M | $14.98M | N/A | | | Details | |
| 2/28/25 | Q424 | -$0.53 | -$0.41 | -$0.12 | $4.55M | $13.4M | N/A | | | Details |
